REV1 Inhibition Enhances Radioresistance and Autophagy

REV1 Inhibition Enhances Radioresistance and Autophagy

Cancer therapy resistance is a persistent clinical challenge. Recently, inhibition of the mutagenic translesion synthesis (TLS) protein REV1 was shown to enhance tumor cell response to chemotherapy by triggering senescence hallmarks. These observations suggest REV1’s important role in determining ca...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kanayo E. Ikeh, Erica N. Lamkin, Andrew Crompton, Jamie Deutsch, Kira J. Fisher, Mark Gray, David J. Argyle, Won Y. Lim, Dmitry M. Korzhnev, M. Kyle Hadden, Jiyong Hong, Pei Zhou, Nimrat Chatterjee
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
translesion synthesis
radioresistance
autophagy
REV1
ionizing radiations
etoposide
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Acceso en línea:https://doaj.org/article/a8b30413ff89465cb626e026f8c27cf5
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/a8b30413ff89465cb626e026f8c27cf5

Ejemplares similares